Warady B A, Bashir M, Donaldson L A
The Children's Mercy Hospital, Kansas City, MO 64108, USA.
Kidney Int. 2000 Jul;58(1):384-9. doi: 10.1046/j.1523-1755.2000.00176.x.
The rarity of fungal peritonitis (FP) in children receiving chronic peritoneal dialysis (PD) has limited the amount of information available regarding the risk factors and management associated with this infection.
We reviewed all cases of FP occurring in patients entered into the dialysis registry of the NAPRTCS between January 1992 and May 1996 in an attempt to identify risk factors for infection, treatment strategies, and patient outcome data. A total of 1592 patients who were less than 21 years of age were enrolled in the dialysis registry and received maintenance PD during the period of observation.
Of the total 1729 episodes of peritonitis in these patients occurring over 1732 patient-years of follow-up, FP accounted for 51 (2.9%) of the episodes. The patients on PD who developed FP were similar to those who did not develop FP with regard to race, gender, dialysis modality, and dialysis access characteristics. The overall peritonitis rate in patients who developed FP was 2.2 episodes per patient-year compared with 0.96 episodes per patient-year in the patients who did not develop this infection (P < 0.0001). In 25 (49%) cases, the FP was the patient's initial episode of peritonitis. Whereas recent antibiotic usage was present in 23 (56%) of 41 patients with FP, there was no statistically significant relationship (P = 0.26) noted between the presence of a gastrostomy and the development of FP. Candida species caused 33 of 42 (78.6%) FP episodes. Therapy consisted of PD catheter removal and Amphotericin B in the majority of patients. Six months after diagnosis, 27 patients remained on PD, twelve patients were receiving hemodialysis, and only three patients had died, in each case for reasons unrelated to their FP episode.
FP is an infrequent cause of peritonitis in children receiving chronic PD. The presence of a gastrostomy does not appear to predispose patients to the development of this infection, and successful therapy most often consists of a combination of antifungal medication and dialysis catheter removal. The outcome of FP in children appears to be more favorable than in the adult dialysis population.
接受慢性腹膜透析(PD)的儿童中真菌性腹膜炎(FP)较为罕见,这限制了关于该感染相关危险因素及管理方面的可用信息量。
我们回顾了1992年1月至1996年5月期间纳入北美儿科肾脏移植协作研究(NAPRTCS)透析登记处的所有FP病例,试图确定感染的危险因素、治疗策略及患者结局数据。共有1592名年龄小于21岁的患者纳入透析登记处,并在观察期间接受维持性PD治疗。
在这些患者1732患者年的随访期间共发生1729次腹膜炎发作,其中FP占51次发作(2.9%)。发生FP的PD患者在种族、性别、透析方式及透析通路特征方面与未发生FP的患者相似。发生FP的患者总体腹膜炎发生率为每人年2.2次发作,而未发生该感染的患者为每人年0.96次发作(P<0.0001)。在25例(49%)病例中,FP是患者的首次腹膜炎发作。41例FP患者中有23例(56%)近期使用过抗生素,但胃造口术的存在与FP的发生之间未发现统计学上的显著关系(P=0.26)。念珠菌属导致42例FP发作中的33例(78.6%)。大多数患者的治疗包括拔除PD导管和使用两性霉素B。诊断后6个月,27例患者仍在接受PD治疗,12例患者接受血液透析,仅3例患者死亡,且每例死亡原因均与FP发作无关。
FP是接受慢性PD治疗儿童腹膜炎的罕见病因。胃造口术的存在似乎不会使患者易患这种感染,成功的治疗通常包括抗真菌药物和拔除透析导管的联合应用。儿童FP的结局似乎比成人透析人群更有利。